Neurodegenerative Disease
AskBio France focuses on clinical research in Huntington’s disease and Parkinson’s disease, with an emphasis on disorders affecting movement, cognition, and progressive brain function. Its funded studies are centered on gene therapy approaches for targeted treatment within the central nervous system.
- Huntington’s disease
- Parkinson’s disease
- Movement disorders
The sponsor’s research activity includes work in adult striatal and intraputaminal brain regions, reflecting a therapeutic interest in conditions with basal ganglia involvement.
Gene Therapy and Brain Delivery
Clinical studies supported by AskBio France are directed toward improving the delivery of genetic therapies into the brain, including administration to deep brain structures relevant to neurodegenerative disease. The research landscape includes efforts focused on targeted central nervous system delivery.
- AB-1001
- AB-1005
- Central nervous system delivery
Its funded trials explore approaches to achieving precise placement of therapeutic material in the caudate nucleus, putamen, and intraputaminal regions.
Neurological Intervention Techniques
AskBio France’s research interests extend to clinically guided methods for administering therapies within the brain, including stereotactic and image-assisted delivery strategies. These studies are aligned with neurological conditions requiring localized treatment in specific brain structures.
- Stereotactic delivery
- Image-guided brain administration
- Intraparenchymal targeting
The sponsor’s portfolio indicates sustained attention to precise neurological targeting in disorders where anatomical specificity is important for therapeutic effect.
